Delivery Order SPE2DB22D3016-SPE2DB26FABS3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $2,108.70. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $1,514.61, with an ultimate completion date of July 31, 2025. This non-competitive delivery order represents a firm fixed price pharmaceutical supply transaction, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award was issued on July 30, 2025, as part of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,604.51. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, executed under a competitive procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,537.84 firm fixed price delivery order on July 29, 2025, for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of July 30, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a $2,076.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of September 24, 2025. This non-set-aside contract was competitively awarded and represents a single delivery transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a $1,089.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract, which is a child order under a larger vehicle, was competitively awarded without a set-aside designation and carries an ultimate completion date of September 5, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,747.44 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of July 29, 2025. This non-competitive delivery order represents a firm fixed price transaction and is classified as a child contract under AmerisourceBergen's larger contract vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $4,218.84, with an ultimate completion date of October 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal government. The order is being fulfilled from the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,903.98 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of June 6, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,081.84 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price delivery order was issued on October 28, 2025, with fulfillment to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FABS3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/ML FlexPen 3ML insulin pens, valued at $2,161.32 with a firm fixed price structure. The contract, issued on November 7, 2025, represents a non-competitive delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA and carries an ultimate completion date of November 10, 2025. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to military and federal healthcare systems worldwide. The NovoLog procurement reflects AmerisourceBergen's ongoing role as a critical vendor for diabetes medications and other pharmaceutical products supporting the Defense Health Agency and other government healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/7/25 |